Melanoma-specific lysis by cloned CD4⁺ and CD8⁺ T cells from actively immunized melanoma patients

Keyphrases

• CD4+ 100%
• Lysis 100%
• CD8+ T Cells 100%
• Melanoma Patients 100%
• Melanoma 100%
• T Cells 55%
• CD8+ 44%
• Allogeneic 44%
• Melanoma Cells 44%
• Tumor Cells 33%
• Peripheral Blood Lymphocytes 33%
• Tumor-infiltrating Lymphocytes 33%
• Lymphocytes 22%
• Major Histocompatibility Complex 22%
• Major Histocompatibility Complex Molecules 22%
• HLA-A2 22%
• Blood Tumors 22%
• No Significant Difference 11%
• B Cells 11%
• MHC Class II 11%
• Immunization 11%
• Complex Allele 11%
• Human Tumor Cells 11%
• Lung Carcinoma 11%
• HLA Matching 11%
• HLA Class I 11%
• HLA Class II Alleles 11%
• HLA Class II 11%
• T-cell Phenotype 11%
• Melanoma Antigens 11%
• Reactivity Pattern 11%
• Lymphoid Tumors 11%

Immunology and Microbiology

• T Cell 100%
• T-Helper Cell 100%
• Cytotoxic T-Cell 100%
• CD4 83%
• Major Histocompatibility Complex 83%
• CD8 66%
• Tumor Cell 66%
• Tumor-Associated Macrophage 50%
• Peripheral Blood Lymphocyte 50%
• Melanoma Cell 50%
• Lymphocyte 33%
• Allele 33%
• B Cell 16%
• Surface Property 16%
• Lymphocyte Clone 16%
• Volume 16%
• Melanoma Cell Line 16%
• Melanoma Antigen 16%

Medicine and Dentistry

• T-Helper Cell 100%
• Cytotoxic T-Cell 100%
• Nodular Melanoma 100%
• T Cell 50%
• Lymphocyte 41%
• Major Histocompatibility Complex 41%
• CD8 Antigen 33%
• Tumor Cell 25%
• Melanoma Cell 25%
• Tumor Infiltrating Lymphocyte 25%
• Allele 16%
• Cyanocobalamin 16%
• B Cell 8%
• Lung Carcinoma 8%
• Melanoma Cell Line 8%
• Autologous Tumor Cell 8%
• Melanoma Antigen 8%
• Lymphatic System Tumor 8%